Medicine & Life Sciences
Hepacivirus
100%
Broadly Neutralizing Antibodies
78%
HIV-1
78%
Vaccines
45%
Neutralizing Antibodies
38%
T-Lymphocytes
33%
SARS Virus
31%
Antibody Formation
29%
Viruses
28%
Virus Diseases
21%
Antibodies
21%
HLA-B57 antigen
21%
Epitopes
20%
Monoclonal Antibodies
18%
Viral Load
18%
Infections
18%
Viremia
18%
Hepatitis C Antibodies
16%
HIV
16%
Coronavirus
16%
Virus Replication
15%
Transplant Recipients
15%
Highly Active Antiretroviral Therapy
14%
Glycoproteins
12%
Mutation
12%
emtricitabine tenofovir alafenamide
12%
Hepatitis C virus glycoprotein E2
12%
B-Lymphocytes
12%
Cobicistat
11%
Severe Acute Respiratory Syndrome
10%
Disulfides
10%
Cytotoxic T-Lymphocytes
10%
Protease Inhibitors
10%
HLA Antigens
10%
Darunavir
10%
Messenger RNA
9%
Emtricitabine
9%
T-Lymphocyte Epitopes
9%
Vaccination
9%
HIV Infections
8%
Clone Cells
8%
Tenofovir
8%
Transplants
8%
Chronic Hepatitis C
7%
Safety
7%
Coinfection
7%
Hepatitis C
6%
Proteins
6%
Immunity
6%
Tablets
6%
Agriculture & Biology
HIV long-term survivors
55%
Hepatitis C virus
43%
Human immunodeficiency virus 1
42%
neutralizing antibodies
23%
T-lymphocytes
17%
viruses
14%
therapeutics
11%
infection
11%
viremia
9%
neutralization
7%
epitopes
7%
vaccine development
7%
monoclonal antibodies
7%
chronic hepatitis C
6%
glycoproteins
6%
viral load
5%
tau-protein kinase
5%